Bresson, Damien; Fousteri, Georgia; Manenkova, Yulia et al. (2011) Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment. J Autoimmun 37:342-51
|
Van Belle, Tom L; Juntti, Therese; Liao, Jeanette et al. (2010) Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment. J Autoimmun 34:445-52
|
Filippi, Christophe M; Juedes, Amy E; Oldham, Janine E et al. (2008) Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. Diabetes 57:2684-92
|
Bresson, D; von Herrath, M (2007) Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun Rev 6:315-22
|
Martinic, Marianne M; Juedes, Amy E; Bresson, Damien et al. (2007) Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice. Diabetes 56:1059-68
|
Burrer, Renaud; Buchmeier, Michael J; Wolfe, Tom et al. (2007) Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies. Am J Pathol 170:557-66
|
Barral, Ana Maria; Thomas, Helen E; Ling, Eleanor M et al. (2006) SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun 27:166-73
|
Burrer, Renaud; von Herrath, Matthias G; Wolfe, Tom et al. (2006) Autoantibodies exacerbate the severity of MHV-induced encephalitis. Adv Exp Med Biol 581:399-402
|
Christen, Urs; von Herrath, Matthias G (2005) Infections and autoimmunity--good or bad? J Immunol 174:7481-6
|
Rhode, Antje; Pauza, Mary E; Barral, Ana Maria et al. (2005) Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J Immunol 175:3516-24
|
Showing the most recent 10 out of 33 publications